Shinichiro Morioka
Overview
Explore the profile of Shinichiro Morioka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
345
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Muto Y, Hosozawa M, Hori M, Iba A, Maruyama S, Morioka S, et al.
J Epidemiol
. 2025 Feb;
PMID: 39924249
BackgroundEvidence of post-COVID-19 condition (PCC) in the Alpha- and Delta-variant dominant waves is limited.MethodsIn a nationwide multicentre cohort study in collaboration with 20 hospitals, we collected data using self-administered questionnaires...
2.
Morioka S, Nikaido M, Tsuzuki S, Kutsuna S, Saito S, Hayakawa K, et al.
J Infect Chemother
. 2024 Nov;
31(2):102561.
PMID: 39551259
No abstract available.
3.
Morioka S, Tsuzuki S, Gu Y, Fujitomo Y, Soeda H, Nakahama C, et al.
J Infect Chemother
. 2024 Oct;
31(2):102532.
PMID: 39366453
Background: A nationwide survey conducted by the Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases in 2020 provided insights into antimicrobial prescription practices among clinic doctors. This...
4.
Maruki T, Morioka S, Miyazato Y, Tsuzuki S, Takezawa K, Kuribayashi S, et al.
J Infect Chemother
. 2024 Jun;
30(11):1194-1196.
PMID: 38944382
Some reports suggest that coronavirus disease 2019 (COVID-19) may affect male reproductive function. There is also concern in Japan that COVID-19 may contribute to the pre-existing decline in male fertility;...
5.
Morioka S, Nikaido M, Tsuzuki S, Kutsuna S, Saito S, Hayakawa K, et al.
J Infect Chemother
. 2024 Feb;
30(8):734-740.
PMID: 38350510
Objective: This study aimed to investigate the epidemiology of post-coronavirus disease 2019 (COVID-19) conditions (PCCs) beyond 3 years and identify factors associated with their persistence longer than 2 years. Study...
6.
Okumura N, Morioka S, Tanaka M, Ohmagari N
Intern Med
. 2024 Feb;
63(18):2585-2586.
PMID: 38311422
No abstract available.
7.
Iwamoto N, Takamatsu Y, Asai Y, Tsuchiya K, Matsuda K, Oshiro Y, et al.
Heliyon
. 2024 Feb;
10(2):e24513.
PMID: 38304834
Background: Antibody testing can easily evaluate the clinical status of patients, aid in the diagnosis of multisystem inflammatory syndrome, and monitor the immunity level in the population. However, the applicability...
8.
Akiyama Y, Morioka S, Tsuzuki S, Yoshikawa T, Yamato M, Nakamura H, et al.
J Infect Chemother
. 2023 Dec;
30(6):488-493.
PMID: 38042298
Introduction: Tecovirimat's application in treating mpox remains under-researched, leaving gaps in clinical and virological understanding. Methods: The Tecopox study in Japan evaluated the efficacy and safety of tecovirimat in patients...
9.
Trends of participants in convalescent plasma donation for COVID-19 in Japan as the pandemic evolved
Suzuki T, Asai Y, Takahashi K, Sanada M, Shimanishi Y, Terada M, et al.
Heliyon
. 2023 Oct;
9(10):e20568.
PMID: 37842585
Background: We aimed to investigate chronological changes in the characteristics of participants in a coronavirus disease 2019 convalescent plasma donation study that may benefit optimal collection methods in the future....
10.
Kato M, Yoshimatsu F, Yamamoto T, Kobayashi N, Kikuchi T, Matsuoka S, et al.
Nihon Koshu Eisei Zasshi
. 2023 Oct;
71(2):103-107.
PMID: 37821379
Objectives In response to the steady rise in the number of cases of mpox in nonendemic countries, starting with an outbreak in the United Kingdom in May 2022, the World...